
AI Identifies Author of Charred Scroll Buried by Vesuvius for 2,000 Years
For the first time, researchers have identified the author and title of a document that's been locked inside a charred scroll for nearly 2,000 years—without peeling back a single layer.
The scroll, PHerc. 172, was recovered from the ruins of Herculaneum, the ancient Roman town buried by the ash and debris of Mount Vesuvius in 79 CE. The scroll is one of three Herculaneum scrolls that now reside at Oxford's Bodleian Libraries.
Thanks to high-resolution scans and some seriously clever machine learning, scholars were able to virtually 'unwrap' the papyrus and read the name inside: On Vices, by the Epicurean philosopher Philodemus.
The treatise—its full name being On Vices and Their Opposite Virtues and In Whom They Are and About What, according to Fine Books Magazine, is basically ancient self-help, exploring how to live a virtuous life by avoiding vice. Philodemus wrote the work in the first century BCE and it is now being read for the first time since it was buried in the devastating volcanic eruption nearly 2,000 years ago.
The discovery—confirmed by multiple research teams—earned the project's collaborators the $60,000 First Title Prize from the Vesuvius Challenge, an open-science competition that's been making ancient texts readable using AI.
In recent years, artificial intelligence has been instrumental in deciphering the ancient, carbonized scrolls from Herculaneum, a Roman town buried by the eruption of Mount Vesuvius in 79. These scrolls, first discovered in the 18th century in what is now known as the Villa of the Papyri, comprise one of the only surviving libraries from the classical world.
Due to their fragile, charred condition, traditional (read: manual) methods of unrolling the scrolls often destroyed them. Now, researchers are using advanced imaging and machine learning to read these texts without ever opening them.
The turning point came in 2015, when scientists used X-ray tomography to read a different ancient scroll from En-Gedi, creating a 3D scan that could be virtually 'unwrapped.' Building on this, researchers at the University of Kentucky developed the Volume Cartographer, a program that uses micro-CT imaging to detect the faint traces of carbon-based ink on the scrolls.
Because the ink contains no metal, unlike many ancient writing materials, a neural network had to be trained to recognize subtle patterns indicating ink on the carbonized papyrus. In 2019, researchers successfully demonstrated this technique, setting the stage for broader applications.
These breakthroughs culminated in the Vesuvius Challenge, launched in 2023 to crowdsource the decoding of unopened scrolls. Participants use AI tools—particularly convolutional neural networks and transformer models—to identify and reconstruct text within the scrolls. In October 2023, the first word ('purple') was read from an unopened scroll, earning a $40,000 prize. The challenge continues, with prizes offered for deciphering additional text and improving the technology.
Brent Seales, a computer scientist at the University of Kentucky and co-founder of the Vesuvius Challenge, told The Guardian that the team's current bottleneck is cleaning, organizing, and enhancing the scan data so that researchers can actually interpret the carbonized ink as text.
Importantly, the digital unwrapping process is guided by human expertise. AI highlights likely areas of ink on the ancient documents, but scholars interpret the patterns to determine if they form coherent words or phrases. The goal is not only to recover lost philosophical texts, many of which are possibly by Epicurus or his followers, but also to establish a scalable system for digitizing and decoding ancient texts—transforming our understanding of the classical world.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Washington Post
2 hours ago
- Washington Post
Dan David Prize names 9 historians as winners of 2025 award
JERUSALEM — The Dan David Prize will award nine historians, archaeologists and filmmakers from around the world with $300,000 for their research, the foundation announced Tuesday. The award winners are researching a vast array of topics, from the notebook of Isaac Newton's roommate to the history and culture of Ethiopian Jews. The academics recently received the prize during a ceremony in Italy.


Medscape
2 hours ago
- Medscape
Lifestyle Changes Boost Medical Therapy for CAD
In patients with chronic stable coronary artery disease (CAD), integrating intensive lifestyle modifications and goal-directed medical therapy — while reserving revascularization for those with severely reduced coronary flow capacity — resulted in improvements in risk factor scores and better clinical outcomes. METHODOLOGY: Researchers in Texas conducted a single-center randomized trial to evaluate the efficacy of combining lifestyle modifications with aggressive medical therapy in patients with subclinical, suspected, or established CAD and factors that put them at a high risk for poor outcomes. Between 2009 and 2017, patients aged 40 years or older were randomly assigned to receive either comprehensive care (n = 513; mean age, 61 years; 67% men) or standard care (n = 515; mean age, 61 years; 69% men). After randomization, all patients underwent baseline stress-rest PET to quantify coronary flow capacity and accordingly defer or guide interventions. Comprehensive care involved intensive lifestyle counseling, regular review of PET results, and targeted steps toward prespecified risk factor goals. Patients also received frequent follow-ups and round-the-clock access to phone or email support. Those without severely reduced coronary flow capacity were managed without invasive interventions. Standard care involved no review of results or contact for support, and PET results were unblinded only for patients with severely reduced coronary flow capacity at a high risk for mortality to consider potential revascularization. The primary outcome was a change in the summed risk score of 16 individual risk factors over a 5-year follow-up period. Major adverse cardiac events, their components, and revascularization after 90 days were assessed as secondary outcomes. TAKEAWAY: At 5 years, patients receiving comprehensive care had a lower summed risk score than those receiving standard care (difference in 5-year change, -1.4; P < .0001), along with significant improvements in individual risk factors such as low-density lipoprotein, BMI, and blood pressure ( P < .01 for all). < .0001), along with significant improvements in individual risk factors such as low-density lipoprotein, BMI, and blood pressure ( < .01 for all). Over 11 years of extended follow-up, the comprehensive care group had 31.4% fewer major adverse cardiac events, 42.7% fewer deaths, 37% fewer deaths or myocardial infarction events, and 35.1% fewer revascularizations than the standard care group ( P < .05 for all). < .05 for all). Only 5.4% of patients underwent revascularization within 90 days, which was primarily guided by the severity of coronary flow capacity. IN PRACTICE: 'The randomized, controlled, blinded 5-year CENTURY trial demonstrates that participants for whom invasive coronary procedures were safely deferred based on [coronary flow capacity] by PET, integrated with comprehensive, intense lifestyle modifications, and aggressive medical treatment targeted to goals significantly improved all risk factor scores with significant reduction in all-cause mortality,' the researchers reported. 'Review of risk factor data, PET images, and frequent supportive participant contact with CENTURY [trial] research staff appeared to enhance adherence of the comprehensive compared with the standard care group,' they added. SOURCE: This study was led by K. Lance Gould, MD, of the University of Texas McGovern Medical School in Houston. It was published online on May 29, 2025, in European Heart Journal . LIMITATIONS: This study was conducted at a single center. About 23% of patients did not participate in the follow-up visits or PET scans. Blinding coronary artery calcium and myocardial perfusion images in patients receiving standard care might have been a source of bias. DISCLOSURES: This study received support from the Weatherhead PET Centre endowment at the University of Texas-Houston. One author reported receiving internal funding from the funding source and being an applicant for FDA-cleared K231731 PET software. One author reported serving as the principal investigator of a trial which receives support from a medical device company. Several authors reported donating any personal honoraria or waiving off their rights to royalties to avoid conflicts of interest.


Medscape
3 hours ago
- Medscape
Hair Cortisone Predicts Metabolic Syndrome in Young Adults
Long-term biological stress, measured using hair glucocorticoid levels, was strongly associated with the presence of metabolic syndrome (MetS) and its components such as waist circumference and triglycerides, with the association being particularly pronounced in younger adults for hair cortisone levels. METHODOLOGY: Researchers in the Netherlands conducted a cross-sectional study to investigate the relationship between hair glucocorticoid levels and the presence of MetS and its components in 1405 adult participants (median age, 49 years; 73.6% women) from the Netherlands Study of Depression and Anxiety cohort. Levels of hair glucocorticoids (cortisol and cortisone) were measured using liquid chromatography-tandem mass spectrometry. Outcomes were the presence of MetS and its individual components that included high-density lipoprotein cholesterol, fasting glucose, and triglyceride levels; diastolic blood pressure; and waist circumference. This study also assessed whether age (≤ 49 vs ≥ 50 years) modified the relationship between hair glucocorticoids and MetS. TAKEAWAY: Hair cortisol (odds ratio [OR], 1.27) and cortisone (OR, 1.32; P < .001 for both) levels were strongly associated with MetS, with the association between hair cortisone and MetS being significantly modified by age (OR, 0.78; P = .003). < .001 for both) levels were strongly associated with MetS, with the association between hair cortisone and MetS being significantly modified by age (OR, 0.78; = .003). The link between hair glucocorticoids and MetS was stronger in younger participants than in older ones for both hair cortisol (OR, 1.52 vs 1.20) and hair cortisone (OR, 1.95 vs 1.14). Hair cortisol and cortisone levels were positively correlated with waist circumference ( P < .001 for both) and triglyceride levels ( P < .025 for both); hair cortisol, but not cortisone, levels were also positively associated with diastolic blood pressure ( P = .034) and negatively associated with high-density lipoprotein cholesterol levels ( P = .035). IN PRACTICE: "In the future, [the study] findings can be used to identify individuals with increased cardiovascular risk," the authors wrote. SOURCE: This study was led by Susanne Kuckuck, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands. It was published online on June 03, 2025, in The Journal of Clinical Endocrinology & Metabolism . LIMITATIONS: The study population was predominantly Caucasian, which limited the generalisability of the findings to other populations and ethnic minorities. Information on diet was not collected; hence, the potential influence of nutritional factors on glucocorticoid metabolism could not be assessed. This study could not show whether elevated hair glucocorticoid levels caused MetS due to its cross-sectional design. DISCLOSURES: This study was supported by Stress in Action, a research project financially supported by the Dutch Research Council and the Dutch Ministry of Education, Culture and Science. The authors declared having no conflicts of interest.